Targeting Macrophage Crosstalk to PASMC by Blunting Inflammatory Phenotype Via SerpinB1 Protects Against

Jiajin Hao1,2, Guangyao Fang3, Xiuchuan Li2

  • 1College of Medicine, Southwest Jiaotong University, Chengdu, Sichuan, China (J.H., D.Y., Q.W., Y.Y., C.L.).

PubMed
Abstract

Insights

Hypoxia amplifies pulmonary hypertension by altering macrophage communication with smooth muscle cells. Downregulation of SerpinB1 in macrophages drives this process, suggesting SerpinB1 as a potential therapeutic target for pulmonary hypertension.

Area of Science:

  • Cardiovascular Biology
  • Immunology
  • Cellular Signaling

Background:

  • Perivascular macrophages contribute to pulmonary hypertension (PH) through crosstalk with pulmonary artery smooth muscle cells (PASMCs).
  • The impact of hypoxia on macrophage-PASMC crosstalk and its underlying mechanisms remain largely unknown.
  • Understanding this interaction is crucial for developing targeted PH therapies.

Purpose of the Study:

  • To investigate how hypoxia affects macrophage crosstalk to PASMCs.
  • To elucidate the molecular mechanisms driving hypoxia-induced changes in this crosstalk.
  • To identify potential therapeutic targets for PH.

Main Methods:

  • Primary mouse PASMCs were co-cultured with conditioned medium from macrophages exposed to normoxia or hypoxia.
  • RNA sequencing was employed to analyze cellular responses.
  • Myeloid-specific SerpinB1-overexpressing mice were utilized to assess SerpinB1's role in vivo.

Main Results:

  • Hypoxia potentiated macrophage-induced PASMC proliferation and inflammatory phenotype.
  • SerpinB1 (serpin family B member 1) was identified as a key mediator, downregulated by hypoxia.
  • Hypoxia-induced SerpinB1 reduction led to caspase-1 activation and amplified pro-proliferative crosstalk.
  • Overexpression of SerpinB1 in myeloid cells ameliorated hypoxia-induced PH phenotypes in mice.

Conclusions:

  • Hypoxia exacerbates PH by downregulating macrophage SerpinB1, promoting inflammatory crosstalk with PASMCs via caspase-1 activation.
  • Targeting macrophage SerpinB1 presents a promising therapeutic strategy for pulmonary hypertension.
  • This study reveals a novel molecular pathway linking hypoxia, macrophage function, and PH pathogenesis.